Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 71 results for "roche"

Pharma firm Roche's drug cocktail doubles chance of holding lung cancer at bay

Pharma firm Roche's drug cocktail doubles chance of holding lu...

Data revealed that 37% of those using Tecentrig, Avastin and chemotherapy did not see their cancer advance DNA, 1 month ago

26 images for roche

Business Standard, 4 weeks ago
Business Standard, 1 month ago
DNA, 1 month ago
Business Standard, 4 months ago
Breaking News, 5 months ago
Daiji World, 5 months ago
Mathrubhumi, 5 months ago
Breaking News, 5 months ago
Breaking News, 5 months ago
First, 6 months ago
Business Standard

Drugmaker Roche to buy US' cancer medicine specialist Ignyta for $1.7 bn

Ignyta will continue its operations in San Diego and will be responsible for the ongoing pivotal study of entrectinib Reuters Last Updated at December 22, 2017 13:30 IST Swiss Drugmaker Roche. Photo: Reuters Swiss drugmaker Roche will buy US cancer drugmaker ...
 Business Standard4 weeks ago Roche to buy U.S. cancer drugmaker Ignyta for $1.7 billion  Reuters4 weeks ago

Roche's star MS medicine Ocrevus wins EU approval

ZURICH (Reuters) - The European Union approved Roche's multiple sclerosis medicine Ocrevus, one the Swiss company's key new drugs that likely neared $1 billion in revenue in its first nine months on the U.S. market.
 Reuters1 week ago Roche scores cancer drug approvals in Europe and U.S.  Reuters1 month ago Roche study finds cancer 'Velcro' that halts T-cell attack  Reuters1 month ago Roche MS drug Ocrevus wins European panel backing  Reuters2 months ago

Roche touts Swiss-led R&D unit after years in Genentech's shadow

ZURICH (Reuters) - Roche is touting prospective new drugs from its long-underperforming Swiss-led research unit after years of leaning on its California-based Genentech arm to restock its medicine cabinet.
 Reuters1 month ago

Hikma wins right to market Roche drug copy in Middle East and North Africa

(Reuters) - Hikma Pharmaceuticals Plc has won exclusive rights to distribute and market its third biosimilar drug - a copy of Roche's blood cancer treatment Rituxanin - in the Middle East and North African markets, it said on Tuesday.
 Reuters1 month ago

Roche, Shire court fight escalates over haemophilia drug

ZURICH (Reuters) - Roche's patent dispute with London-listed Shire over the Swiss drugmaker's new haemophilia drug Hemlibra has escalated, with Shire filing a new motion in a U.S. court that Roche says aims to stop some patients from getting its medicine.
 Reuters1 month ago Roche's Foundation Medicine wins FDA blessing for new cancer test  Reuters1 month ago Roche hemophilia drug wins FDA nod, with a warning  Reuters2 months ago FDA backs Roche's Gazyva in first-line follicular lymphoma  Reuters2 months ago

Roche: Tecentriq cocktail slows kidney cancer progression

ZURICH (Reuters) - Combining Roche's Tecentriq immunotherapy with its older drug Avastin for the initial treatment of advanced kidney cancer reduced the risk of the disease worsening or of death in certain patients, the Swiss drugmaker said on Monday.
 Reuters1 month ago Roche announces trial successes in cancer, haemophilia  Reuters2 months ago Roche says Tecentriq combination cuts lung cancer risk  Reuters2 months ago

Roche lymphoma drug drives high remission rate, longer survival: study

(Reuters) - An experimental Roche Holding AG drug, added to standard therapy, led to a far higher rate of remission and helped patients with an advanced, aggressive blood cancer live significantly longer than the standard treatment alone, according to data ...
 Reuters1 month ago

Roche, AbbVie leukemia drug superior to older medicine in study

(Reuters) - Patients with a type of leukemia that had relapsed who received the new drug Venclexta in combination with Rituxan went significantly longer without the disease worsening than those treated with Rituxan and Treanda, according to interim results ...
 Reuters1 month ago

Roche stock up $12 billion on cancer, hemophilia trials; rivals hit

ZURICH (Reuters) - Roche shares were lifted on Monday by two trial wins for its new cancer and hemophilia drugs, potential blockbusters that the Swiss drugmaker is counting on to offset shrinking revenue from older medicines.
 Reuters2 months ago Roche gets $12 billion stock boost from positive cancer, hemophilia results  Reuters2 months ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less